ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

ACS, SU2C Committ $20 Million For Lung Cancer Dream Team

January 31, 2014

Voluntary Organizations: Myles Cunningham elected ACS President

November 8, 1996

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

NCI Advisory Group, Other Cancer Meetings For Sept,. Oct,. Future

August 25, 1989

Conference asks NCAB To Develop Guidelines For Clinical Alerts; Must Be Investigator-Initiated

February 9, 1990

All 59 CCOP Awards Announced Heavy In Northeast, Fair In Midwest; Amounts, Priority Scores Listed

June 3, 1983